1. Background
2. Methods
3. Results
| Patient (No) Sex, Age at First Surgery | Intellectual Delay, Verbal Skills, Behaviors, Disordered Sleep | Seizures, Treatment | Movement Disorders | Craniofacial Abnormalities | Other |
|---|---|---|---|---|---|
| 1. male, 7 mo | Severe, nonverbal, excitable/laughing, disordered sleep | Staring episodes, 2 - 3 week levetiracetam | Tremulous limbs | Microcephaly, plagiocephaly, strabismus | GERD |
| 2. female, 2 y | Severe, nonverbal, excitable/laughing, disordered sleep | Abnormal electroencephalography, no seizures | Ataxia, tremulous limbs | Microcephaly, plagiocephaly, hypertelorism | |
| 3. female, 7 ya | Mild delay only | None | None | Frontonasal dysplasia | |
| 4. female, 16 y | Severe, nonverbal, excitable/laughing | Tonic-clonic, several mo Valproic acid, zonisamide, levetiracetam | Ataxia, tremulous limbs | Microcephaly, strabismus | |
| 5. male, 8 y | Severe, nonverbal, excitable/laughing, disordered sleep | Tonic-clonic, 2 - 3 mo Clobazam, valproic acid, topiramate | Ataxia, tremulous limbs | Strabismus | Scoliosis eosinophilic esophagitis |
| 6. male, 29 y | Severe, nonverbal, excitable/laughing, disordered sleep | Spastic seizures, well controlled Valproic acid | Wheelchair bound, tremulous limbs | Small head, hypertelorism, protruding tongue |
Abbreviations: GERD; gastroesophageal reflux disease; mo, month; y, year.
aMild presentation of Angelman syndrome secondary to methylation imprinting defect in chromosome 15q11.2-q13, this was not secondary to maternal deletion, but parents declined further genetic work up to determine precise genetic defect.
| Patient (No), Age, Weight (kg) | Procedure Duration (min) | Anesthetic Typea | Analgesiab | PACU Duration (min) Disposition |
|---|---|---|---|---|
| 1 | ||||
| 7 mo, 7 | MLB, EGD, 78 | Sevo/Prop | - | 68, outpatient |
| 8 mo, 7 | MRI, 117 | Sevo/Prop | - | 47, outpatient |
| 2 | ||||
| 2 y, 10 | MRI, 111 | Sevo/Prop | - | 101, outpatient |
| 2 y, 11 | Strabismus, 141 | Sevo | Fent/APAP | 95, outpatient |
| 3 y, 12 | T/A, MLB, 93 | Sevo | NSAID | 44, outpatient |
| 3 | ||||
| 7 y, 33 | T/A, 58 | Sevo | Morphine, LA | 32, outpatient |
| 4 | ||||
| 16 y, 47 | Dental, 90 | Mid/Prop/Des | Fent/NSAID, LA | 234, outpatient |
| 5 | ||||
| 8 y, 33 | EGD, 51 | Mid/ Sevo/Prop** | - | 36, outpatient |
| 8 y, 33 | EGD, 35 | Mid/ Sevo/Prop** | - | 45, outpatient |
| 8 y, 33 | EGD, 34 | Mid/ Sevo/Prop** | - | 22, outpatient |
| 8 y, 31 | T/A, EGD, 111 | Sevo, Atracuriumc | Fent, LA | 36, ICUd |
| 9 y, 31 | EGD, 24 | Sevo** | - | 39, outpatient |
| 20 y, 106 | EGD, 34 | Sevo/Prop** | - | 14, outpatient |
| 6 | ||||
| 28 y, 78 | LP, 44 | Mid/Prop/Iso Succinylcholine | LA | 53, ward |
| 28 y, 78 | PICC, 65 | Mid/Prop†† | Fent, LA | 43, ward |
| 28 y, 78 | CT, 22 | Mid/Prop†† | - | 57, ward |
| 34 y, 89 | LP, 77 | Mid/Prop/Ket†† | Fent, LA | 12, ICUe |
| 34 y, 89 | CT, 39 | Mid/Prop†† | - | 116, ward |
Abbreviations: APAP, acetaminophen; CT, computerized tomography scan; Des, desflurane; EGD, esophagogastroduodenoscopy; Fent, fentanyl; ICU, intensive care unit; Iso, isoflurane; Ket, ketamine; LA, infiltration of procedure site with local anesthetic; LP, lumbar puncture; min , minute; mo, months; MLB, microlaryngoscopy and bronchoscopy; MRI, magnetic resonance imaging scan; Mid, midazolam; NSAID, nonsteroidal antiinflammatory drug; PICC, peripherally inserted central catheter; Prop, propofol; Sevo, sevoflurane; T/A, adenotonsillectomy; y, years.
aCases were performed under general endotracheal anesthesia unless noted with ** to indicate general mask anesthesia or †† to indicate monitored anesthesia care.
bNo patient was administered opioid or nonopioid analgesic during Phase I postanesthesia recovery.
cAtracurium 10 mg was administered with induction, but was not reversed.
dPlanned ICU admission for postoperative monitoring of airway effort.
eAdmitted to ICU for treatment of on-going sepsis that was unrelated to procedure.
4. Discussion
| Feature | Implications |
|---|---|
| Intellectual disability | Require anesthesia for minor procedures |
| Nonverbal | Pain assessment can be confounded; parental input should be sought (13) |
| Happy dispositiona | Reduced ability to assess the pain (Figure 1). |
| Disordered sleep | Monitor for postoperative sleep disturbances |
| GABA-A Abnormalities | Potential for increased/decreased sensitivity to benzodiazepines (Pt#4b) (8, 24) |
| Seizure disorders | Continue perioperative antiepileptic regimen |
| Monitor for increased seizure activity | |
| Craniofacial abnormalities | Potential for airway difficulty(Pt#6b) (7, 24, 28) |
| Increased vagal tone | Potential for profound bradycardia (7, 11) |
| Can be recalcitrant to anticholinergic medications | |
| Potential asystole during laughing outbursts (9, 10) | |
| Closely monitor heart rhythm during laparoscopic surgery | |
| Closely monitor all patients with previous vagal episodes | |
| Muscular abnormalities | Truncal hypotonia, ataxic gait, truncal hypertonia in adulthood |
| Potential implications for neuromuscular drug administration | |
| Respiratory abnormalities | Postoperative respiratory failure and disordered breathing patterns have been described (2, 14, 17) |
aUnprovoked episodes and outbursts of laughing, clapping hands, etc.
bIndicates patient and complication was described in this cohort.
